VI4 Stock Chart & Stats
€15.70
€0.10(1.05%)
At close: 4:00 PM EDT
€15.70
€0.10(1.05%)
Day’s Range― - ―
52-Week Range€7.95 - €16.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€670.53M
Enterprise Value€745.99
Total Cash (Recent Filing)€99.20M
Total Debt (Recent Filing)€373.60M
Price to Earnings (P/E)35.2
Beta1.09
Next Earnings
Nov 24, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.53
Shares Outstanding42,148,254
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)1.05
Price to Sales (P/S)0.59
P/FCF Ratio26.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€16.27Price Target Upside3.61% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.76
Revenue Forecast (FY)€744.45M
Bulls Say, Bears Say
Bulls Say
Recurring Aftermarket DemandVarex benefits from an installed base of imaging equipment that requires tube replacements and related service-driven components over time. This aftermarket exposure can provide recurring demand beyond new-system shipments, supporting business durability through OEM production-cycle variability.
Profitability RecoveryThe return to positive operating profit and net income, alongside relatively stable gross margins, indicates that the business retains underlying earnings potential. If sustained, this recovery can support reinvestment and strengthen operating resilience, although the recent history shows execution remains important.
Strategic Acquisition FitTeledyne’s planned acquisition could strengthen Varex’s strategic position by combining its X-ray tubes and photon-counting detectors with complementary detector and vacuum-electronics capabilities. Minimal overlap may preserve product focus while expanding opportunities across medical imaging and industrial inspection.
Bears Say
Weak Cash ConversionNegative free cash flow despite positive net income indicates that accounting profitability is not currently translating into internally generated cash. Persistently weak conversion would reduce flexibility to fund investment, manage obligations, or withstand softer demand without relying more heavily on external financing.
Volatile EarningsThe movement from strong results to losses and then only a modest TTM net margin demonstrates uneven earnings quality and limited profit cushion. This volatility makes durable forecasting more difficult and leaves results vulnerable if costs rise or revenue growth weakens.
Meaningful LeverageAlthough leverage has improved from prior periods, debt remains meaningful relative to equity and the company has recently experienced loss years. A renewed earnings decline could therefore place greater pressure on financial flexibility, especially while current cash generation remains weak.
Varex Imaging News
VI4 FAQ
What was Varex Imaging Corporation’s price range in the past 12 months?
Varex Imaging Corporation lowest stock price was €7.95 and its highest was €16.10 in the past 12 months.
What is Varex Imaging Corporation’s market cap?
Varex Imaging Corporation’s market cap is €670.53M.
When is Varex Imaging Corporation’s upcoming earnings report date?
Varex Imaging Corporation’s upcoming earnings report date is Nov 24, 2026 which is in 72 days.
How were Varex Imaging Corporation’s earnings last quarter?
Varex Imaging Corporation released its earnings results on Aug 10, 2026. The company reported €0.266 earnings per share for the quarter, beating the consensus estimate of €0.181 by €0.086.
Is Varex Imaging Corporation overvalued?
According to Wall Street analysts Varex Imaging Corporation’s price is currently Undervalued.
Does Varex Imaging Corporation pay dividends?
Varex Imaging Corporation does not currently pay dividends.
What is Varex Imaging Corporation’s EPS estimate?
Varex Imaging Corporation’s EPS estimate is 0.25.
How many shares outstanding does Varex Imaging Corporation have?
Varex Imaging Corporation has 42,148,254 shares outstanding.
What happened to Varex Imaging Corporation’s price movement after its last earnings report?
Varex Imaging Corporation reported an EPS of €0.266 in its last earnings report, beating expectations of €0.181. Following the earnings report the stock price went up 0.952%.
Which hedge fund is a major shareholder of Varex Imaging Corporation?
Currently, no hedge funds are holding shares in DE:VI4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Varex Imaging Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€16.27 (3.61% Upside)
€16.27 (3.61% Upside)
Blogger Sentiment
Neutral
DE:VI4 Sentiment 50%
Sector Average 62%
Sector Average 62%
Technicals
SMA
Positive
20 days / 200 days
Momentum
60.52%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.48%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Varex Imaging Corporation
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
VI4 Company Deck
VI4 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted solid execution on guidance, margin resilience (non‑GAAP gross margin at the high end), successful debt refinancing and clear technology and industrial pipeline momentum (CT, photon-counting, cargo systems). Offsetting these positives are modest top‑line growth (+1% YoY), a GAAP loss, margin erosion versus the prior year (down ~240 bps), elevated inventory and short‑term working capital pressures. Management provided multi-quarter visibility (annual guidance) and actions (India ramp, pricing/contract renewal levers) that could improve margins over time, but near-term growth and margin recovery remain modest.View all DE:VI4 earnings summariesVI4 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€16.27
▲(3.61% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month










